Report highlights significant improvements in adolescent well-being in India
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
The company plans to add 1700 beds by FY27 through the organic route
Pharma Solutions operates 10 research and development and/or production sites globally
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
The company recently received CEP certificate approval for Losartan Potassium by EDQM
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
The company reported lifetime high EBIDTA of Rs. 250 crores
Subscribe To Our Newsletter & Stay Updated
